Cath Lab

The cardiac catheterization laboratory is used for diagnostic angiograms and percutaneous coronary interventions (PCI). Cath labs have also seen expanding use in recent years for transcatheter structural heart procedures. Some hospitals also share these labs with other subspecialties for catheter-based procedures in electrophysiology (EP), interventional radiology, peripheral artery disease (PAD), carotid and neuro interventional procedures and vascular surgery.

An Illinois appellate judge upheld a pervious trial victory that cleared and central Illinois cardiologist Amit Dande, MD, and Prairie Cardiovascular Consults LLP of alleged misdiagnosis of the severity of a patient's heart condition that led to his death prior to a schedule percutaneous coronary intervention (PCI).

Illinois cardiologist not held responsible for patient's death while waiting for angiogram

A judge upheld a previous trial victory that cleared Prairie Cardiovascular Consults of alleged mishandling of a patient and not fully understanding the severity of the heart condition prior to their death.

Thumbnail

Implementing a same-day PCI discharge pathway boils down to correct patient selection

Safety is key to which individuals are selected for SDD, and there can be benefits to both patients and health systems as this becomes the predominant model of care in elective PCI.

Video of Mahadevappa Mahesh, PhD, incoming-AAPM president, professor of radiology and a medical physicist, Johns Hopkins University School of Medicine, explains key trends in imaging physics presented at the Radiological Society of North America (RSNA) 2023 meeting.

6 key trends in medical imaging physics

Mahadevappa Mahesh, PhD, incoming American Association of Physicists in Medicine president, discusses key developments in the specialty. 

doctor looking at CLTI patient's leg

FDA grants bioresorbable scaffold system its breakthrough device designation to treat infrapopliteal lesions

The new drug-eluting device was designed to provide both stability and flexibility to patients presenting with below-the-knee lesions.  

An FDA panel will discuss its recommendations related to Abbott's TriClip G4 transcatheter edge-to-edge repair (TEER) system for tricuspid regurgitation.

FDA advisory panel votes in favor of Abbott’s TriClip device for tricuspid regurgitation

After hours of discussion, the panel determined that the benefits of using the TriClip G4 TEER system to treat TR outweigh any potential risks. 

doctor examines patient data on their tablet

New American College of Cardiology registry focuses on data from outpatient ambulatory surgical centers

The ACC launched its latest registry knowing that volumes at these outpatient facilities are expected to rise in the years ahead. 

Best in KLAS 2024: New rankings for cardiovascular information systems, hemodynamic solutions

Hospital end users ranked the CVIS and hemodynamic systems they use, shedding light on their working relationships with IT vendors. 

FDA approves first transcatheter tricuspid valve replacement device, the EVOQUE system from Edwards Lifesciences

Edwards makes history, receives FDA approval for transcatheter tricuspid valve replacement device

The approval, based on positive results from the TRISCEND II trial, represents a significant milestone for the treatment of severe tricuspid regurgitation.